This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Societe Civile Bioprojet, Societe Civile Bioproject. Active years: 2006-2011.
Company Filing History:
Years Active: 2006-2011
Title: Fabien Leurquin: Innovator in Medicinal Chemistry
Introduction
Fabien Leurquin is a notable inventor based in London, GB, recognized for his contributions to medicinal chemistry. He holds three patents that focus on compounds with significant pharmacological potential, particularly in relation to histamine H-receptors.
Latest Patents
Leurquin's latest patents involve the use of a compound of formula (A), wherein W is a residue that imparts antagonistic and/or agonistic activity at histamine H-receptors when attached to an imidazole ring in the 4(5) position. The variables R and R may be identical or different, representing each independently a lower alkyl or cycloalkyl. Alternatively, they may form a saturated nitrogen-containing ring or a non-aromatic unsaturated nitrogen-containing ring, among other configurations. These innovations are aimed at preparing medicaments that act as antagonists and/or agonists at the H-receptors of histamine.
Career Highlights
Throughout his career, Fabien Leurquin has worked with prominent companies such as Société Civile Bioprojet and Société Civile Bioproject. His work in these organizations has contributed to advancements in the field of medicinal chemistry and drug development.
Collaborations
Leurquin has collaborated with esteemed colleagues, including Jean-Charles Schwartz and Jean-Michel Arrang. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.
Conclusion
Fabien Leurquin's work exemplifies the intersection of innovation and medicinal chemistry. His patents and collaborations highlight his commitment to advancing therapeutic options for various medical conditions.